Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2010
06/23/2010CN101744903A Dropping liquid for treating otitis media and preparation method thereof
06/23/2010CN101744877A Selfheal quality control method
06/23/2010CN101744817A tetrandrine for treating keratopathy
06/23/2010CN101744487A Chinese medicinal tea health care pillow
06/23/2010CN101100689B Method for preparing pearl active peptide
06/23/2010CN101020659B 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application
06/22/2010US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer'
06/22/2010US7741346 Vision defects; anticancer agents; antitumor agents
06/22/2010US7741335 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis
06/22/2010US7741331 Use treating atherosclerosis, angiogenesis, type II diabetes, diabetic retinopathy, cancer, and asthma; for example, 3-ethyl-1-propyl-8-(1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl)-1,3,7-trihydropurine-2,6-dione
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741047 Using histone binding protein (RBAp48) as evaluative tool in identifying modulators for treatment of sjogren's syndrome
06/22/2010US7740831 Compositions for potentiating glutathione
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2442296C Therapeutic agents for retinochoroidal disorders comprising steroids as active ingredients
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/17/2010WO2010068078A1 Method for surgically treating corneal diseases
06/17/2010WO2010066125A1 A short peptide, preparation and uses thereof
06/17/2010WO2010028088A3 Sulfur-linked compounds for treating opthalmic diseases and disorders
06/17/2010US20100152279 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
06/17/2010US20100152257 Antagonists of lysophosphatidic acid receptors
06/17/2010US20100152255 Organic Compounds
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152176 Modulators of Muscarinic Receptors
06/17/2010US20100151064 Thiazolhydrazides for treatment of neurodegenerative diseases
06/17/2010US20100150992 Methods for Treatment of Ophthalmic Disease of an External Ophthalmic Tissue
06/17/2010US20100150908 Affinity matured CRIg variants
06/17/2010US20100150893 Methods of organ regeneration
06/16/2010EP2196218A2 Use of anti-TNFalpha antibodies and another drug
06/16/2010EP2196199A1 Treatment of phantom phenomena
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010EP2194986A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
06/16/2010EP2194780A1 Method of treating glaucoma using rasagiline
06/16/2010EP1863802B1 Substituted piperidines as renin inhibitors
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010CN1993118B Aqueous eye drops with accelerated intraocular migration permeability
06/16/2010CN1824060B Applicaiton of a combination for preparing medicine and food dual purpose Chinese medicinal nutritive product for preventing true myopia
06/16/2010CN1824058B Medicine and food dual purpose Chinese medicinal product for preventing and treating nightblindness and its manufacturing method
06/16/2010CN1824044B Application of a combination for preparing medicine and food dual purpose product for preventing and treating synchysis
06/16/2010CN101743015A The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
06/16/2010CN101743009A Pharmaceutical compositions and methods of treating dry eye disorders
06/16/2010CN101735212A Controlled synthesis of ziprasidone and compositions thereof
06/16/2010CN101732731A Lentiviral vector-mediated gene transfer and uses thereof
06/16/2010CN101732673A Orally taken Chinese medicament for treating Meniere's disease
06/16/2010CN101732577A Medicament for treating Meniere's disease
06/16/2010CN101732546A Chinese medicament for treating upsurging yellow humor of spleen-stomach deficiency-cold syndrome
06/16/2010CN101732532A Visual sense feeling relaxation apparatus
06/16/2010CN101732506A External oculentum for treating amblyopia, astigmatism, strabismus, myopia and visual fatigue of teenagers
06/16/2010CN101732483A Health product manufactured by using extracts of Changbai mountain wild blueberry as raw material
06/16/2010CN101732480A Chinese medicament for treating upsurging yellow humor of spleen-stomach excess heat syndrome
06/16/2010CN101732350A Method for preparing nano pearl powder
06/16/2010CN101732238A Mitomycin c ophthalmic gel
06/16/2010CN101732132A Medical care instrument of ears and brain
06/16/2010CN101731754A Health-care cigarette
06/16/2010CN101731400A Fat-removal slimming tea and preparation method thereof
06/16/2010CN101269220B Rapamycin eye-in implantation type medicine release system with bletilla striata glue as carrier
06/16/2010CN101181490B Chinese medicine composition orally taken for curing glaucoma
06/16/2010CN101028459B Oral Chinese-medical composition for treating chronic otitis media
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737178 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA)
06/15/2010US7736655 Neuroprotectants; angoigenesis inhibitors; transcription factors; host cells
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010CA2493391C Novel thiophene glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
06/15/2010CA2419875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/10/2010WO2010065834A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
06/10/2010WO2010064737A1 Heterocyclic compound and use of the same
06/10/2010WO2010064705A1 Novel 7-substituted dihydropyranopyrimidine derivative having h4 receptor antagonistic activity
06/10/2010WO2010064636A1 Ophthalmic composition
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010032875A3 Heterocyclic carboxamide compounds
06/10/2010WO2010011349A3 Pyrimidine-2,4-diamines as jak2 kinase inhibitors for treatment of inflammation
06/10/2010WO2009149486A3 Compounds for treating beta-amyloidoses
06/10/2010WO2009104051A3 Combinational therapeutics for treatment of prostate cancer using epoxy encapsulated magnetic particles and rnai medicine
06/10/2010US20100145441 Therapeutic agents for angiogenesis-related diseases comprising chondromodulin-i as active ingredient
06/10/2010US20100145180 Apparatus for physical measurements of the eye
06/10/2010US20100144844 RNAi-MEDIATED INHIBITION OF H1F1A FOR TREATMENT OF OCULAR ANGIOGENESIS
06/10/2010US20100144809 Novel benzamidine derivatives useful as potassium channel modulators
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144792 Neurite formation promoter
06/10/2010US20100144782 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/10/2010US20100144768 Kinase inhibitor compounds
06/10/2010US20100144756 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/10/2010US20100144755 Novel Compounds
06/10/2010US20100144748 Methods involving aldose reductase inhibitors
06/10/2010US20100144736 Novel biphenyl thio-urea derivatives useful as potassium channel modulators
06/10/2010US20100144718 Treatment of diseases modulated by a h4 receptor agonist
06/10/2010US20100144676 Oleyl phosphocholine
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100144661 Sodium channel blockers
06/10/2010US20100144631 Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof
06/10/2010US20100144609 Methods using cyclosporin in treating patients with intraocular lenses
06/10/2010US20100143459 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 531